REGEN THERAPEUTICS
ReGen (Therapeutics Plc) was formed in February 1998 to develop Colostrinin™, a proline-rich polypeptide complex derived from mammalian colostrum. The complex and the peptides within it are viewed as having potential utility in neurodegenerative illnesses such as Alzheimer’s disease, Parkinson’s Disease, Multiple Sclerosis and Amyotrophic Lateral Sclerosis.
REGEN THERAPEUTICS
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
1998-02-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.regentherapeutics.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API WordPress Apache Microsoft Azure DNS AJAX Libraries API Amazon Route 53 Sectigo SSL Sectigo Domain SSL
Similar Organizations
Grespo AB
Grespo AB is a biomedical company based in Stockholm
InhaTarget Therapeutics
InhaTarget Therapeutics is a spin-off company.
Isarna Therapeutics
Isarna Therapeutics is a biotechnology company.
Qurient Therapeutic
Qurient Therapeutic is a biotech company.
Rekindle Therapeutics
Rekindle Therapeutics is a biotechnology company.
Theranyx
Theranyx is a French biotech company
Tonus Therapeutics
Tonus Therapeutics is a young biotech company.
Veolia Water Solutions
Veolia Water Solutions is a bio-tech company.
Official Site Inspections
http://www.regentherapeutics.com
- Host name: obpuk2-03.nexcess.net
- IP address: 87.76.19.109
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
